Act Fast and Take Part in a Humira Study!

JB Editor
  • Infopshere clinical research is working with Abbott Laboratories in the enrollment of participants for the IRB-approved clinical trial investigating the efficacy of a dosage of 80mg adalimumab in the treatment of Rheumatoid arthritis.

    Dr. Stephen R. White, a board certified Rheumatologist, is the primary investigator on this trial.


    The researchers are studying whether the a monthly dose of adalimumab 80mg is as good as the bi-weekly dosage of 40mg.


    The trial will go on for 24 weeks. A small percentage of participants will be assigned to receive a placebo for the first 12 weeks -- that's how the reseachers will learn if the drug actually works or not.

    Add This Infographic to Your Website or Blog With This Code:


    To be eligible, you must meet the following:

    • Be 18 or older
    • Have been diagnosed with Rheumatoid Arthritis for a minimum of three months
    • Is not currently taking any medications for RA (or on a stable dose of MTX)
    • Is in stable health


    The deadline to apply for the trial is Oct. 31!

    Call 818-222-6868 or e-mail Adrienne Scollans, patient relations, at

    They are located in West Hills at 7345 Medical Center Drive, West Hills, CA 91307.


    Questions or comments? Call and ask or post them here.

Published On: September 22, 2008